Antithrombotic treatment in atrial fibrillation.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18508982.
- Also identified by DOI 10.1136/hrt.2005.066944.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atrial fibrillation (AF) can significantly increase morbidity and mortality. It is gaining in clinical and economic importance, being the most commonly encountered tachyarrhythmia in clinical practice. Stroke is the most serious complication. Evidence from AF antithrombotic treatment trials is reviewed, risk stratification of patients with AF is discussed, and recommendations for anticoagulation are presented.
Medical subject headings
- Anticoagulants
- Aspirin
- Atrial Fibrillation
- Fibrinolytic Agents
- Platelet Aggregation Inhibitors
- Warfarin